Adverse events after stopping clopidogrel in post-acute coronary syndrome patients insights from a large integrated healthcare delivery system Academic Article uri icon

Overview

MeSH Major

  • Acute Coronary Syndrome
  • Myocardial Infarction
  • Platelet Aggregation Inhibitors
  • Ticlopidine

abstract

  • We observed a clustering of adverse events in the 0 to 90 days after stopping clopidogrel. This clustering of events was not present among patients stopping ACE inhibitors. These findings are consistent with a possible rebound platelet hyper-reactivity after stopping clopidogrel and additional platelet studies are needed to confirm this effect.

publication date

  • May 2010

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1161/CIRCOUTCOMES.109.890707

PubMed ID

  • 20354221

Additional Document Info

start page

  • 303

end page

  • 8

volume

  • 3

number

  • 3